It is possible that NEP inhibition may be effective in other experimental AAA models that do not involve AngII as the initiating stimulus, since NEP inhibition at some doses (1 mg/kg per day) elevated circulating AngII concentrations that would be anticipated to worsen AngII-induced AAAs. The gene discussed is AGT; the disease is triple-A syndrome.